FSPKF
Price
$22.10
Change
+$1.40 (+6.76%)
Updated
Jul 1 closing price
Capitalization
8.78B
GTHP
Price
$0.28
Change
+$0.02 (+7.69%)
Updated
Jul 8 closing price
Capitalization
7.4M
Interact to see
Advertisement

FSPKF vs GTHP

Header iconFSPKF vs GTHP Comparison
Open Charts FSPKF vs GTHPBanner chart's image
Fisher & Paykel Healthcare
Price$22.10
Change+$1.40 (+6.76%)
Volume$2.38K
Capitalization8.78B
Guided Therapeutics
Price$0.28
Change+$0.02 (+7.69%)
Volume$11.84K
Capitalization7.4M
FSPKF vs GTHP Comparison Chart in %
Loading...
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FSPKF vs. GTHP commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPKF is a Buy and GTHP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (FSPKF: $22.10 vs. GTHP: $0.28)
Brand notoriety: FSPKF and GTHP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FSPKF: 12% vs. GTHP: 146%
Market capitalization -- FSPKF: $8.78B vs. GTHP: $7.4M
FSPKF [@Medical Specialties] is valued at $8.78B. GTHP’s [@Medical Specialties] market capitalization is $7.4M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FSPKF’s FA Score shows that 0 FA rating(s) are green whileGTHP’s FA Score has 0 green FA rating(s).

  • FSPKF’s FA Score: 0 green, 5 red.
  • GTHP’s FA Score: 0 green, 5 red.
According to our system of comparison, FSPKF is a better buy in the long-term than GTHP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FSPKF’s TA Score shows that 2 TA indicator(s) are bullish while GTHP’s TA Score has 2 bullish TA indicator(s).

  • FSPKF’s TA Score: 2 bullish, 1 bearish.
  • GTHP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, FSPKF is a better buy in the short-term than GTHP.

Price Growth

FSPKF (@Medical Specialties) experienced а 0.00% price change this week, while GTHP (@Medical Specialties) price change was +19.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.28%. For the same industry, the average monthly price growth was +1.39%, and the average quarterly price growth was +0.40%.

Reported Earning Dates

FSPKF is expected to report earnings on May 28, 2025.

GTHP is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Medical Specialties (+1.28% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FSPKF($8.78B) has a higher market cap than GTHP($7.4M). FSPKF has higher P/E ratio than GTHP: FSPKF (55.87) vs GTHP (8.86). GTHP YTD gains are higher at: 83.333 vs. FSPKF (9.406). FSPKF has higher annual earnings (EBITDA): 434M vs. GTHP (-4.08M). FSPKF has more cash in the bank: 121M vs. GTHP (1.84M). GTHP has less debt than FSPKF: GTHP (2.11M) vs FSPKF (146M). FSPKF has higher revenues than GTHP: FSPKF (1.59B) vs GTHP (30K).
FSPKFGTHPFSPKF / GTHP
Capitalization8.78B7.4M118,683%
EBITDA434M-4.08M-10,637%
Gain YTD9.40683.33311%
P/E Ratio55.878.86631%
Revenue1.59B30K5,296,667%
Total Cash121M1.84M6,587%
Total Debt146M2.11M6,916%
FUNDAMENTALS RATINGS
FSPKF vs GTHP: Fundamental Ratings
FSPKF
GTHP
OUTLOOK RATING
1..100
4987
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
79100
SMR RATING
1..100
46100
PRICE GROWTH RATING
1..100
4434
P/E GROWTH RATING
1..100
9778
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTHP's Valuation (83) in the null industry is in the same range as FSPKF (93). This means that GTHP’s stock grew similarly to FSPKF’s over the last 12 months.

FSPKF's Profit vs Risk Rating (79) in the null industry is in the same range as GTHP (100). This means that FSPKF’s stock grew similarly to GTHP’s over the last 12 months.

FSPKF's SMR Rating (46) in the null industry is somewhat better than the same rating for GTHP (100). This means that FSPKF’s stock grew somewhat faster than GTHP’s over the last 12 months.

GTHP's Price Growth Rating (34) in the null industry is in the same range as FSPKF (44). This means that GTHP’s stock grew similarly to FSPKF’s over the last 12 months.

GTHP's P/E Growth Rating (78) in the null industry is in the same range as FSPKF (97). This means that GTHP’s stock grew similarly to FSPKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FSPKFGTHP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMMF28.870.12
+0.43%
WisdomTree Emerging Markets Mltfctr
MAYT34.870.02
+0.05%
AllianzIM U.S. Large Cp Buffer10 May ETF
AVSU69.140.02
+0.03%
Avantis Responsible US Equity ETF
TLTP22.43N/A
+0.02%
Amplify Bloomberg U.S.Trs 12% Prm IncETF
FNCL74.16-0.59
-0.80%
Fidelity MSCI Financials ETF

FSPKF and

Correlation & Price change

A.I.dvisor tells us that FSPKF and ANSLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and ANSLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSPKF
1D Price
Change %
FSPKF100%
N/A
ANSLY - FSPKF
26%
Poorly correlated
N/A
OLYMY - FSPKF
25%
Poorly correlated
+1.98%
TMDX - FSPKF
25%
Poorly correlated
-0.35%
BRSYF - FSPKF
22%
Poorly correlated
N/A
TCHBF - FSPKF
22%
Poorly correlated
N/A
More

GTHP and

Correlation & Price change

A.I.dvisor tells us that GTHP and FSPKF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GTHP and FSPKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTHP
1D Price
Change %
GTHP100%
+5.77%
FSPKF - GTHP
22%
Poorly correlated
N/A
GRRMF - GTHP
6%
Poorly correlated
N/A
GNGBY - GTHP
5%
Poorly correlated
+1.92%
FZMD - GTHP
3%
Poorly correlated
N/A
HOCPY - GTHP
1%
Poorly correlated
+2.81%
More